| Financial Year |
March 31 2023 |
| Monetary Funds |
3,248,257,644.82 |
| Held-for-trading Financial Assets |
3,270,478.22 |
| Notes Receivable |
323,932,310.40 |
| Accounts Receivable |
1,205,843,021.69 |
| Advances to Suppliers |
1,102,001,940.47 |
| Other Receivables |
2,505,404,260.38 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,720,897,021.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
975,393.18 |
| Other Current Assets |
630,753,958.27 |
| Total Current Assets |
12,018,221,860.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,039,874,555.77 |
| Investment Properties |
1,639,757,000.00 |
| Fixed Assetes |
4,623,904,954.33 |
| Under-construction Projects |
835,487,718.91 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,434,724,821.91 |
| R&D expenses |
2,310,717.59 |
| Goodwill |
95,783,718.96 |
| Long-Term Deferred and Prepaid Expenses |
15,619,705.11 |
| Deferred Income Tax Assets |
241,655,870.46 |
| Other Non-Current Assets |
208,493,666.43 |
| Sub-Total of Non-Current Assets |
13,273,538,344.16 |
| Total Assets |
25,291,760,204.33 |
| Short-Term Loans |
1,763,689,630.13 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,241,677,715.45 |
| Accounts Payable |
775,694,609.83 |
| Accounts Received In Advance |
69,961,160.77 |
| Employee Compensation Payable |
123,212,634.21 |
| Taxes Payable |
310,291,959.74 |
| Interest Payable |
-- |
| Dividend Payable |
2,661,483.87 |
| Other payables |
1,183,886,477.27 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
595,807,489.62 |
| Other Current Liabilities |
528,503,792.03 |
| Sub-Total of Current Liabilities |
8,039,606,152.03 |
| Long-term Loans |
1,052,850,000.00 |
| Bonds Payable |
500,000,000.00 |
| Long-Term Accounts Payable |
139,769,276.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
55,995,600.00 |
| Deferred Income Tax Liabilities |
1,096,099,472.50 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,114,446,531.27 |
| Total Liabilities |
11,154,052,683.30 |
| Paid-In Capital(Or Share Stock) |
2,188,072,878.00 |
| Capital Surplus |
3,631,522,293.75 |
| Surplus Reserve |
2,543,851,039.27 |
| LESS:Treasury Stock |
103,823,808.06 |
| Undistributed Profits |
4,710,865,466.04 |
| Minority Stockholder's Interest |
1,004,703,628.19 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,133,003,892.85 |
| Owner's Equity（Stockholder's Equity） |
14,137,707,521.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
25,291,760,204.34 |
